Asset Details
Do you wish to reserve the book?
Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL
Do you wish to request the book?
Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL
2024
Overview
Loss of arterial smooth muscle cells (SMCs) and abnormal accumulation of the extracellular domain of the NOTCH3 receptor (Notch3 ECD ) are the 2 core features of CADASIL, a common cerebral small vessel disease caused by highly stereotyped dominant mutations in NOTCH3 . Yet the relationship between NOTCH3 receptor activity, Notch3 ECD accumulation, and arterial SMC loss has remained elusive, hampering the development of disease-modifying therapies. Using dedicated histopathological and multiscale imaging modalities, we could detect and quantify previously undetectable CADASIL-driven arterial SMC loss in the CNS of mice expressing the archetypal Arg169Cys mutation. We found that arterial pathology was more severe and Notch3 ECD accumulation greater in transgenic mice overexpressing the mutation on a wild-type Notch3 background (Tg Notch3 R169C ) than in knockin Notch3 R170C/R170C mice expressing this mutation without a wild-type Notch3 copy. Notably, expression of Notch3 -regulated genes was essentially unchanged in Tg Notch3 R169C arteries. We further showed that wild-type Notch3 ECD coaggregated with mutant Notch3 ECD and that elimination of 1 copy of wild-type Notch3 in Tg Notch3 R169C was sufficient to attenuate Notch3 ECD accumulation and arterial pathology. These findings suggest that Notch3 ECD accumulation, involving mutant and wild-type NOTCH3, is a major driver of arterial SMC loss in CADASIL, paving the way for NOTCH3-lowering therapeutic strategies.
Publisher
American Society for Clinical Investigation
Subject
